|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2024―Mar―29 |
Effects of Azvudine on the Low-Risk Patients Infected with COVID-19 Omicron Variants: A Retrospective Case-Control Study |
Jie Wang, Chenxi Zhang, Hailong Bing, Liwei Sun, Wenchuan Guan, Hang Bao, Jieshi Ba, Dachao Yun, Dan Wang, Jiwei Wang, Ningwei Yin, Hongkai Lian, Qinjun Chu, Xiaogao Jin |
2 |
[GO] |
2023―Dec―21 |
Synthesis of New 1,4-Dihydropyridine Scaffold Thiadiazole and Triazole Moiety and in silico Molecular Interaction Study of SARS-CoV-2 Mpro and ACE2 Protease |
Radhakrishnan Surendraku, Pitchai Sangan, Akbar Idhayadhul, Anis Ahamed, Reham M. A lahmadi |
3 |
[GO] |
2023―Oct―21 |
Safety Analysis of Antiviral Drugs Approved for COVID-19 in Saudi Arabia |
Syed Mohammed Basheeruddin Asdaq, Muath Mousa Almutairi, Marwan Suleiman Alharbi, Faisal Ghazi Alharbi, Abdullah Abdulrahman Alharbi, Saleh Saud Al-Harbi, Ali Ibrahim Almoteer, Ahmad Alenazi, Abdullah Saud Altayar, Raed Alharbi, Awwadh Alqarni, Bader Hussain Alamer, Ebtesam Abdulrahman Jibreel, Syed Arif Hussain, Syed Imam Rabbani |
4 |
[GO] |
2022―Apr―02 |
Predictive Analysis of COVID-19 Symptoms with CXR Imaging and Optimize the X-Ray Imaging Using Segmentation Thresholding Algorithm-An Evolutionary Approach for Bio-Medical Diagnosis |
N. Prabhakara, S. Anandha Pr, M. Kamali, C. Sabarinath, I. Chandra, V. Prabhu |
5 |
[GO] |
2021―Dec―08 |
In silico Screening of Phytochemicals as Potential Inhibitors of SARS-CoV-2 Mpro and Human ACE-2 |
Anurag Chaudhary, Ritu Tomar, Syed Mohammed B, Mohd. Imran, Saleh I. Alaqel, Abdulhakeem S. Alamri, Walaa F. Alsanie, Majid Alhomrani, Mandeep Kumar Aror, Dheeraj Bisht, Kamal Dua, Rajeshwar Kamal Kant, Sachin Singh, Naira Nayeem, Abida . |
6 |
[GO] |
2021―Dec―08 |
Sitagliptin Combined HIV-TAT as Potential Therapeutic Targeting of SARS-CoV-2 Virus |
Hani Z. Asfour, Tarek S. Ibrahim, Osama A. A. Ahme, Nabil A. Alhakamy, Usama A. Fahmy, Mohammed W. Al-Rabi |
7 |
[GO] |
2021―Oct―18 |
Inhibitory Activity of Balanites aegyptiaca Phytochemicals on Main Protease of SARS-CoV-2: Virtual Screening and Molecular Dynamics Simulation |
Isam Abu Zeid |
8 |
[GO] |
2021―Oct―14 |
Are the Newest Angiotensin Receptor Blockers Preferred than the Old Members in COVID-19 Patients with Cardiovascular Comorbidity? |
Hussam A.S. Murad, Suleiman S. Al-Kayy, Turky A. Alkaabi |
9 |
[GO] |
2021―Sep―23 |
Spectrum of Immunopathogenesis in Coronavirus Disease 2019 (COVID-19): An Updated Review |
Mohamed M. El-Khaw, Mohamed A. Saleh, Ramadhan Oruch, Gouda H. Attia |